Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures

NCT05582018 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Hepatocellular Carcinoma
Metastatic Liver Cancer

Interventions

DEVICE: BioTraceIO 360

Sponsor

Techsomed Medical Technologies LTD